Woman checks a glucose meter at a bright kitchen table beside a glass of water and an amber supplement bottle, with a subtle green molecular graphic behind her.

Does Berberine Actually Lower Blood Sugar?

Oct 16, 2026

0 comments

Berberine has been called a natural alternative to metformin and, more recently, “nature’s Ozempic.” Those comparisons are catchy. They are also much stronger than the evidence.

Clinical trials do suggest that berberine can improve fasting and after-meal glucose in some people with type 2 diabetes. The average changes are meaningful enough to study further, but the trials are usually short, the doses vary, and the quality of the evidence is uneven.

The fairest conclusion is that berberine may support glucose control. It is not a proven replacement for prescribed diabetes treatment, and the results from high-dose ingredient trials cannot be assigned to every supplement that contains berberine.

What the newest large review found

A 2024 systematic review and meta-analysis combined 50 randomized trials with 4,150 participants who had type 2 diabetes. When berberine was used by itself, fasting glucose fell by an average of 0.59 mmol/L—about 11 mg/dL—and two-hour post-meal glucose fell by 1.57 mmol/L, or about 28 mg/dL.

When berberine was added to glucose-lowering medication, the pooled results also favored the combination for fasting glucose, post-meal glucose, insulin resistance, and hemoglobin A1c. The average A1c difference was 0.69 percentage points.

Those numbers sound persuasive, but three details matter:

Most studies lasted only one to three months. That can show a biomarker change, not long-term protection from heart, kidney, eye, or nerve complications.
The most common daily dose was 900 to 1,500 milligrams. A product containing a smaller amount is not the intervention studied in those trials.
The studies were heterogeneous. Populations, background medications, berberine products, doses, and comparison groups differed.

Meta-analysis can produce a more precise average, but it cannot repair every limitation in the studies being combined.

Why the evidence still deserves caution

A separate 2023 umbrella meta-analysis pooled earlier meta-analyses of randomized trials. It reported average reductions in fasting glucose, A1c, insulin, and HOMA-IR, a marker of insulin resistance. The A1c estimate was 0.57 percentage points lower with berberine.

That reinforces the direction of the signal, but umbrella reviews often include overlapping trials. Fifty studies in one review plus several meta-analyses in another does not necessarily mean completely independent evidence.

The most useful reality check came from a 2025 overview of systematic reviews. It found favorable results across many metabolic outcomes, but the authors rated high-certainty evidence as rare. For type 2 diabetes, high-quality evidence was limited to adverse-event outcomes; certainty declined substantially for most efficacy findings because of issues such as small studies, inconsistent reporting, and geographically concentrated trial populations.

So the pattern is not “berberine does nothing.” The pattern is “the biomarkers often move in a favorable direction, but our confidence in the size, durability, and generalizability of the effect is limited.”

What about comparisons with metformin?

The most quoted comparison comes from a 2008 pilot trial. Thirty-six adults with newly diagnosed type 2 diabetes were randomized to berberine or metformin at 500 milligrams three times daily for three months. Both groups improved, and the investigators described similar glucose-lowering effects.

That is interesting. It is not enough to declare berberine equivalent to metformin.

The study was small, short, and not designed as a modern noninferiority trial. It did not establish comparable long-term safety, cardiovascular benefit, kidney outcomes, manufacturing consistency, or effectiveness across a broad population. In the wider study cohort, about one-third of participants reported transient gastrointestinal symptoms.

Another 2008 randomized trial assigned 116 adults with type 2 diabetes and dyslipidemia to one gram of berberine daily or placebo for three months. Fasting glucose, A1c, triglycerides, total cholesterol, and LDL cholesterol improved versus placebo. Again, this was a useful short-term biomarker trial—not a test of whether berberine prevents diabetes complications.

Berberine is not a medication-free loophole

“Natural” does not mean inactive. Berberine can cause abdominal pain, constipation, diarrhea, nausea, and vomiting. The National Center for Complementary and Integrative Health also warns that berberine can interact with medicines and should not be used during pregnancy or breastfeeding or given to infants.

Extra care is warranted when someone already takes glucose-lowering medication. Combining products that lower glucose can increase the chance of an excessive drop, especially when insulin or a sulfonylurea is involved. Medication interactions are not limited to diabetes drugs, so a pharmacist or clinician should review the full list.

If you have diabetes, the practical rule is simple: do not stop, reduce, or replace prescribed therapy because a supplement contains berberine. Use home glucose readings and laboratory follow-up to judge what is actually happening, and make treatment changes with the clinician managing your care.

Where Core Control fits

Core Control is Take Control Science’s stimulant-free daily metabolic-support formula. The current label lists a two-capsule serving with 200 milligrams of berberine HCl, plus 150 milligrams of alpha-lipoic acid, 200 micrograms of chromium, 150 milligrams of magnesium, B vitamins, bergamot, grape seed, hibiscus, lemon verbena, and BioPerine.

The dose distinction is essential. The 2024 berberine meta-analysis reported that most trials used 900 to 1,500 milligrams per day. Core Control’s 200-milligram amount is therefore not dose-equivalent to those trials, and the finished multi-ingredient formula has not been clinically tested to reproduce their glucose or A1c results.

Where it may fit is as a consistent supplement routine for an adult who understands those boundaries and wants broad metabolic support alongside nutrition, activity, sleep, and appropriate medical care. The label directs adults to take two capsules daily with eight ounces of water, or as directed by a healthcare professional. It also advises consulting a healthcare professional before use if you are pregnant or nursing, take medication, or have a medical condition.

That is a more honest role than calling any supplement a treatment substitute.

A practical decision checklist

Know the goal. “Metabolic support” is different from treating diagnosed diabetes or replacing medication.
Read the actual dose. Do not assume that the word berberine on the label means the product matches doses used in clinical trials.
Review medications first. Ask a pharmacist or clinician about interactions, especially if you use glucose-lowering drugs.
Track an objective outcome. Fasting glucose, post-meal readings, and A1c are more useful than judging a supplement by how it feels.
Keep the foundation visible. Food quality, resistance and aerobic exercise, sleep, body composition, and prescribed care have broader evidence than any single supplement.
Stop for side effects. Persistent gastrointestinal symptoms, unexpected low readings, or other new symptoms deserve review.

The bottom line

Berberine has a real clinical signal. Across randomized trials, it has improved short-term glucose markers, particularly in people with type 2 diabetes. But the evidence is less settled than the marketing.

Most trials are short, most studied substantially higher daily doses than many combination supplements provide, and strong evidence for long-term clinical outcomes is missing.

Use berberine as a possible adjunct—not a medication replacement, not a shortcut around the basics, and not a reason to ignore dose differences.

This Field Note is for general educational purposes and is not individualized medical advice. Do not change diabetes medication or use berberine during pregnancy or breastfeeding without appropriate clinical guidance. People taking medication or living with a medical condition should review any supplement with a qualified clinician or pharmacist.

Sources and further reading

THE CONVERSATION

Let's talk about it.

Have a question, perspective, or experience to share? We'd love to hear from you. Join the conversation and help us build a more informed wellness community.

No comments yet. Be the first to join the conversation.